Bayer
Novartis launches Facebook ‘retina app’
October 15, 2013Medical Communications AMD, Bayer, Lucentis, Novartis, set your sights
Novartis, the world’s biggest eye-care drugmaker, has launched a new Facebook retina app to raise awareness of retinal disease. The …
Bayer pill gains FDA approval despite shutdown
October 9, 2013Sales and Marketing Bayer, FDA, adempas, hypertension
In the midst of the US shutdown of government agencies the FDA has managed to approve Bayer’s Adempas for patients …
Oliver Brandicourt joins Bayer from Pfizer
September 30, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Oliver Brandicourt, Pfizer
Bayer Healthcare has appointed Pfizer’s executive Olivier Brandicourt to head up its healthcare division. Taking over from interim head Wolfgang …
Bayer slammed for ‘nightcaps’
September 26, 2013Medical Communications, Sales and Marketing ABPI, Bayer, PMCPA
Bayer has come under fire from the PMCPA for providing late-night drinks to delegates at a conference in Amsterdam, exceeding …
Bayer faces China investigation
September 16, 2013Medical Communications, Sales and Marketing Bayer, China, corruption
Bayer partners with US academics
September 13, 2013Research and Development, Sales and Marketing Bayer, Cancer, broad, oncology
Bayer HealthCare and a prestigious US academic institution have signed a five-year deal to find new oncology treatments. The German …
Eylea receives new European approval
August 30, 2013Research and Development, Sales and Marketing Bayer, CRVO, Eylea, Lucentis, Novartis, wet AMD
Eylea trial boost in DME
August 7, 2013Research and Development, Sales and Marketing Bayer, DME, Eylea, regenenron
The rival treatment to Novartis’ Lucentis has posted encouraging new study results in patients with diabetic macular oedema (DME). In …
Bayer signs cancer vaccine research deal
August 6, 2013Research and Development, Sales and Marketing Bayer, Vaccine, compugen
Bayer has entered into a new collaboration with Compugen to develop cancer vaccines aimed at helping the body fight off …
Eliquis poised for new US approval
July 12, 2013Sales and Marketing BMS, Bayer, DVT, Eliquis, warfarin
Pfizer and Bristol-Myers Squibb have submitted their oral direct Factor Xa inhibitor Eliquis to the FDA to prevent deep vein …
FDA has Xarelto concerns
July 2, 2013Sales and Marketing Bayer, Boehringer, FDA, Pradaxa, Xarelto
The FDA is unsure about an application to further extend the licence for Janssen and Bayer HealthCare’s blood thinner Xarelto …
Bayer takes over Conceptus
June 6, 2013Sales and Marketing Bayer, Conceptus
The Bayer Group, which contains Bayer HealthCare, has taken over US contraception specialist Conceptus in a $1.1 billion deal. The …
NICE green light for Eylea
May 31, 2013Sales and Marketing Bayer, NICE, Regeneron
NICE has recommended Bayer’s injection Eylea as a treatment for neovascular (wet) age-related macular degeneration (AMD) if the manufacturer offers …
Xarelto gets ACS indication
May 29, 2013Sales and Marketing ACS, Bayer, Xarelto
Bayer HealthCare’s bloodthinner Xarelto has expanded its reach in Europe with approval for secondary prevention after an acute coronary syndrome …
Bayer hires chief information officer
May 23, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, information
Johannes Schubmehl has been appointed chief information officer of Bayer HealthCare. Schubmehl succeeded Matthias Moritz, who left the company at …
Latest content
